Targeted pain relief from the earliest diagnosed stages of canine Osteoarthritis (OA) Galliprant is a first-in-class prostaglandin receptor antagonist (PRA), a non-COX inhibiting NSAID. It specifically targets the EP4 receptor, the primary mediator of canine OA pain and inflammation1. You can start treatment from the earliest diagnosed stages.
Availability: Out of Stock - on backorder and will be dispatched once in stock.
